Vancomycin concentrations during cardiopulmonary bypass in pediatric cardiac surgery: a prospective study

被引:1
|
作者
Ferrari, Fiorenza [1 ]
Benegni, Simona [2 ]
Marinari, Eleonora [2 ]
Haiberger, Roberta [2 ]
Garisto, Cristiana [2 ]
Rizza, Alessandra [2 ]
Giorni, Chiara [2 ]
Quattrone, Maria Giovanna [1 ]
Arpicco, Silvia [3 ]
Muntoni, Elisabetta [3 ]
Milla, Paola [3 ]
Ricci, Zaccaria [4 ,5 ]
机构
[1] IRCCS Fdn Policlin San Matteo, Intens Care Unit, Pavia, Italy
[2] IRCCS, Bambino Gesu Childrens Hosp, Pediat Cardiac Intens Care Unit, Dept Cardiol & Cardiac Surg, Rome, Italy
[3] Univ Turin, Dept Drug Sci & Technol, Turin, Italy
[4] Azienda Osped Univ Meyer, Florence, Italy
[5] Univ Firenze, Florence, Italy
来源
PERFUSION-UK | 2022年 / 37卷 / 06期
关键词
vancomycin; pediatric cardiac surgery; cardiopulmonary bypass; pharmacokinetics; pharmacodynamics; EXTRACORPOREAL MEMBRANE-OXYGENATION; POPULATION PHARMACOKINETICS; ANTIBIOTIC-PROPHYLAXIS; INFECTIONS; GUIDELINE; OUTCOMES; SOCIETY; DRUGS;
D O I
10.1177/02676591211006828
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Few data are available regarding intraoperative plasma concentrations of vancomycin administered as prophylaxis in pediatric cardiac surgery. The aims of this study were to investigate during pediatric cardiac surgery with cardiopulmonary bypass(CPB) the attainment of the area-under-the-curve of the vancomycin serum concentrations versus time over surgery to minimum inhibitory concentration ratio(AUC(intra)/MIC) of 400 (mg x h)/l and/or a target concentration of 15-20 mg/l. Methods: In a prospective study, 40 patients divided into four subgroups (neonates, infants, children <10 years-old, > 10 years-old) undergoing cardiac surgery with cardiopulmonary bypass (CPB) were enrolled. A slow vancomycin bolus of 20 mg/kg, up to a maximum dose of 1000 mg was administered before skin incision and a further dose of 10 mg/kg (up to 500 mg) at CPB start. Vancomycin samples were collected intraoperatively at four time points. Results: The median (interquartile range) age was 241.5 days (47-3898) and the median weight was 7.1 kg (3.1-37). The median AUC(intra)/MIC was 254.73 (165.89-508.06). In 11 patients the AUC(intra)/MIC target was not reached. Neonates displayed the lowest AUC(intra)/MIC values, and these were significantly lower than those of children > 10 years old (p = 0.02). Vancomycin concentrations were above the maximal target of 20 mg/l in 82.5% and 80% of patients at surgery and CPB start, respectively. At CPB and surgery end, 42.5% of patients showed vancomycin concentrations above 20 mg/l and 42.5% below 15 mg/l. Patients > 10 years old showed the highest peak values whereas neonates were those with the lowest troughs. AUC(intra)/MIC correlated with age(r:0.36, p = 0.02), weight(r:0.35, p = 0.03), intraoperative protein value(r:0.40, p = 0.01), CPB priming volume/kg(r:-0.33, p = 0.04), CPB duration(r:0.36, p = 0.02) and vancomycin troughs(r:0.35, p = 0.04). Conclusions: An AUC(intra)/MIC > 400 target was not reached in one-quarter of children undergoing heart surgery. Vancomycin peaked before the start of surgery and neonates were those with the lowest troughs. Vancomycin concentrations are affected by CPB hemodilution and by patients' age and weight.
引用
收藏
页码:553 / 561
页数:9
相关论文
共 50 条
  • [1] Methylprednisolone Plasma Concentrations During Cardiac Surgery With Cardiopulmonary Bypass in Pediatric Patients
    van Saet, Annewil
    Zeilmaker-Roest, Gerdien A.
    Veen, Kevin M.
    de Wildt, Saskia N.
    Sorgel, Fritz
    Stolker, Robert J.
    Bogers, Ad J. J. C.
    Tibboel, Dick
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [2] Cardiopulmonary bypass for pediatric cardiac surgery
    Hirata, Yasutaka
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2018, 66 (02) : 65 - 70
  • [3] Cardiopulmonary bypass for pediatric cardiac surgery
    Yasutaka Hirata
    General Thoracic and Cardiovascular Surgery, 2018, 66 : 65 - 70
  • [4] Effect of ultrafiltration during cardiopulmonary bypass for pediatric cardiac surgery
    Watanabe, T
    Sakai, Y
    Mayumi, T
    Shimomura, T
    Song, MH
    Tajima, K
    Suenaga, Y
    Kawaradani, Y
    Saito, Y
    Yamada, T
    ARTIFICIAL ORGANS, 1998, 22 (12) : 1052 - 1055
  • [5] Vancomycin sequestration during cardiopulmonary bypass surgery
    Krivoy, N
    Yanovsky, B
    Kophit, A
    Zaher, A
    Bar-El, Y
    Adler, Z
    Gaitini, L
    Milo, S
    JOURNAL OF INFECTION, 2002, 45 (02) : 90 - 95
  • [6] Modification of Vancomycin Dosing in Cardiac Surgery With Cardiopulmonary Bypass
    Wang, Lei
    Yu, Xu-ben
    Zhou, Zi-Ye
    Wang, Jue
    Zheng, Liu-Pu
    Dai, Ying
    Wang, Yu-Zhen
    Zhang, Xiao-Shan
    Chen, Chuang
    Shi, Da-Wei
    Zhang, Chun-Hong
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (04): : 490 - 497
  • [7] Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery
    García, MPO
    Martí-Bonmatí, E
    Serrano, JG
    Gómez, IG
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (03) : 260 - 265
  • [8] Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass -: a microdialysis study
    Mand'ak, J.
    Pojar, M.
    Malakova, J.
    Lonsk, V
    Palicka, V
    Zivny, P.
    PERFUSION-UK, 2007, 22 (02): : 129 - 136
  • [9] TISSUE AND PLASMA CONCENTRATIONS OF ANTIBIOTIC DURING CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS - MICRODIALYSIS STUDY
    Pojar, Marek
    Mandak, Jiri
    Malakova, Jana
    Jokesova, Iveta
    BIOMEDICAL PAPERS-OLOMOUC, 2008, 152 (01): : 139 - 145
  • [10] PHARMACOKINETICS OF INTRAVENOUS VANCOMYCIN IN PEDIATRIC CARDIOPULMONARY BYPASS-SURGERY
    HATZOPOULOS, FK
    STILECALLIGARO, IL
    RODVOLD, KA
    SULLIVANBOLYAI, J
    DELNIDO, P
    LEVITSKY, S
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (04) : 300 - 304